Morgan Stanley Raises Victory Capital (NASDAQ:VCTR) Price Target to $40.00
Victory Capital (NASDAQ:VCTR – Free Report) had its price target lifted by Morgan Stanley from $39.00 to $40.00 in a research note published on Tuesday,...
StockNews.com Upgrades Vodafone Group Public (NASDAQ:VOD) to Buy
StockNews.com upgraded shares of Vodafone Group Public (NASDAQ:VOD – Free Report) from a hold rating to a buy rating in a report published on Tuesday...
Teradyne, Inc. (NASDAQ:TER) Receives Average Rating of “Hold” from Brokerages
Teradyne, Inc. (NASDAQ:TER – Get Free Report) has received an average recommendation of “Hold” from the fifteen research firms that are presently covering the company,...
JPMorgan Chase & Co. Cuts Apellis Pharmaceuticals (NASDAQ:APLS) Price Target to $64.00
Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) had its target price cut by JPMorgan Chase & Co. from $72.00 to $64.00 in a research report released...
Needham & Company LLC Begins Coverage on Artiva Biotherapeutics (NASDAQ:ARTV)
Needham & Company LLC began coverage on shares of Artiva Biotherapeutics (NASDAQ:ARTV – Free Report) in a research note published on Tuesday morning, MarketBeat.com reports....
Canaccord Genuity Group Reaffirms Buy Rating for Atara Biotherapeutics (NASDAQ:ATRA)
Canaccord Genuity Group reaffirmed their buy rating on shares of Atara Biotherapeutics (NASDAQ:ATRA – Free Report) in a research report report published on Tuesday morning,...